ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES Trademark

Trademark Overview

On Friday, October 6, 2017, a trademark application was filed for ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES with the United States Patent and Trademark Office. The USPTO has given the ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES trademark a serial number of 87636178. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Monday, November 17, 2025. This trademark is owned by Sanofi Biotechnology. The ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES trademark is filed in the Education & Entertainment Services category with the following description:

Educational services, namely, arranging and conducting classes, seminars, conferences, and workshops for patients with immune system related diseases and disorders, namely, asthma, atopic dermatitis, and nasal polyposis, in the fields of immunology and inflammatory diseases
advent advances in type 2 immune diseases

General Information

Serial Number87636178
Word MarkADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES
Filing DateFriday, October 6, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateMonday, November 17, 2025
Registration Number5677678
Registration DateTuesday, February 19, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 27, 2018

Trademark Statements

Goods and ServicesEducational services, namely, arranging and conducting classes, seminars, conferences, and workshops for patients with immune system related diseases and disorders, namely, asthma, atopic dermatitis, and nasal polyposis, in the fields of immunology and inflammatory diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized wording "ADVENT" below two slightly offset chevrons facing the opposite direction. The stylized wording "ADVANCES IN TYPE 2 IMMUNE DISEASES" appears below the wording "ADVENT".
Pseudo MarkADVENT ADVANCES IN TYPE TWO IMMUNE DISEASES; ADVENT ADVANCES IN TYPE TO IMMUNE DISEASES
NOT AVAILABLE"ADVANCES IN TYPE 2 IMMUNE DISEASES"

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, October 13, 2017
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi Biotechnology
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGentilly 94250
FR
Party NameSanofi Biotechnology
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi Biotechnology
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75008 Paris
FR

Trademark Events

Event DateEvent Description
Tuesday, October 10, 2017NEW APPLICATION ENTERED
Friday, October 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 14, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, November 30, 2017ASSIGNED TO EXAMINER
Saturday, December 9, 2017NON-FINAL ACTION WRITTEN
Saturday, December 9, 2017NON-FINAL ACTION E-MAILED
Saturday, December 9, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 23, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 25, 2018SUSPENSION LETTER WRITTEN
Thursday, January 25, 2018LETTER OF SUSPENSION E-MAILED
Thursday, January 25, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 1, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, February 11, 2018ASSIGNED TO LIE
Friday, February 16, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 16, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 27, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, April 26, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, May 23, 2018OPPOSITION INSTITUTED NO. 999999
Friday, January 11, 2019OPPOSITION DISMISSED NO. 999999
Friday, January 11, 2019OPPOSITION TERMINATED NO. 999999
Friday, January 11, 2019TTAB RELEASE CASE TO TRADEMARKS
Tuesday, February 19, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Monday, February 19, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 10, 2025TEAS SECTION 8 RECEIVED
Saturday, November 8, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 17, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, November 17, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords

diseases immune type advances advent namely atopic asthma disorders dermatitis polyposis inflammatory immunology fields